Novak Djokovic purchases 80% of Danish biotech firm

by   |  VIEW 5068

Novak Djokovic purchases 80% of Danish biotech firm

20-time Grand Slam champion Novak Djokovic has 80% of Danish biotech firm QuantBioRes, per Reuters. QuantBioRes is aiming to develop a medical treatment, not a vaccine, against COVID-19. QuantBioRes CEO Ivan Loncarevic told Reuters the investment was made in 2020 June but declined to reveal how much it was.

Djokovic, ranked at No. 1 in the world, hasn't yet been vaccinated. Djokovic refused to get vaccinated before the start of the season but blew to Australia after being granted a medical exemption for the Australian Open.

The Australian government wasn't willing to let an umvaccinated Djokovic play as they canceled his visa. On Sunday, Djokovic lost his Australia visa appeal and was deported from the country.

Djokovic accepted the court's decision

After being stripped of a chance to fight for a 10th Australian Open title, Djokovic packed his things and left Australia.

"I would like to make a brief statement to address the outcome's of today's Court hearing, I will now be taking some time to rest and recuperate, before making any further comments beyond this," Djokovic said in a statement.

"I'm extremely disappointed with the Court ruling to discuss my application for judicial review of the Minister's decision to cancel my visa, which means I cannot stay in Australia and participate in the Australian Open.

"I respect the Court's ruling and I will cooperate with the relevant authorities in relation to my departure from the country. "I'm uncomfortable that the focus of the past weeks has been on me and I hope that we can all now focus on the game and tournament I love, I would like to wish the players, tournament officials, staff, volunteers and fans all the best for the tournament.

"Finally, I would like to thank my family, friends, team, supporters, fans and my fellow Serbians for your continued support. You have all been a great source of strength for me."